EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.681
https://www.valueinhealthjournal.com/article/S1098-3015(22)00882-8/fulltext
Title : EE433 A US Claims Database Analysis of the Impact of Fremanezumab on Migraine-Related Health Care Utilization and Costs in Patients with Common Comorbidities, Acute Medication Overuse, or Difficult-to-Treat Migraine
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00882-8&doi=10.1016/j.jval.2022.04.681
First page :
Section Title :
Open access? : No
Section Order : 10610
Categories :
Tags :
Regions :
ViH Article Tags :